Evaluation of Glycated Albumin and Microalbuminuria as Early Risk Markers of Nephropathy in Type 2 Diabetes Mellitus 1280-1283
The Role of ‘Paraoxonase– 1 Activity’ as an Antioxidant in Coronary Artery Diseases 1284-1287
Nitric Oxide Levels in Patients with Chronic Renal Disease 1288-1290
The Evaluation of Serum Amylase in the Patients of Type 2 Diabetes Mellitus, with a Possible Correlation with the Pancreatic Functions 1291-1294
Correlation of the Serum Insulin and the Serum Uric Acid Levels with the Glycated Haemoglobin Levels in the Patients of Type 2 Diabetes Mellitus 1295-1297
A Study on Interleukin —1Beta and Lipid Profile as Markers of Cardiovascular Risk in Rheumatoid Arthritis 1298-1302
A Study of Serum Apolipoprotein A1, Apolipoprotein B and Lipid Profile in Stroke 1303-1306
All the research studies published were performed in accordance to the Declaration of Helsinki. Written consent was obtained from all the included subjects (or the responsible next kin), where ever applicable. In case reports or any article which includes patients images, permission was sought from the patient (or the responsible next kin) for publication. Whether or not this has been explicitly stated in the manuscript, this was declared by the authors at the time of submission of manuscript to the journal. In a rare event, if the consent could not be obtained due to loss of patient for follow up or death or loss of contact, even after reasonable effort, the editors then decided on case by case basis, weighing on the individual contribution the report will make to advancement of medical literature.